Clinical Trial Update: Angiotensin in Septic Kidney Injury Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating angiotensin for septic kidney injury is ongoing, with current status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Sepsis
• Septic Shock

Drugs mentioned

• Angiotensin (angiotensin)

Snippet

Sponsor: Austin Health | Conditions: Acute Renal Failure, Sepsis | Phase 2 | Status: UNKNOWN